Dr Adams & Dr Kumar talk about a novel sirolimus drug-eluting balloon

Dr. George Adams highlighted a promising advancement in coronary intervention: a novel sirolimus drug-eluting balloon – SELUTION SLR™ DEB. “This DEB mimics the pharmacokinetics of a limus-eluting stent, delivering sirolimus to the vessel wall for up to 90 days – a sustained anti-inflammatory effect without a permanent implant”.